Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Treatment of severe 2009 H1N1 infection with convalescent plasma will reduce mortality.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Hong Kong
• Treatments: Oseltamivir

Criteria

Inclusion Criteria:

• adult patients ≥ 18 years old with written informed consent given by patient or next-of-kin

• laboratory confirmatory diagnosis of 2009 H1N1 infection by positive RT-PCR from respiratory specimens

• required intensive care within 7 days of onset of symptoms

Exclusion Criteria:

• age 18 years old or below

• known hypersensitivity to immune globulin

• known IgA deficiency